# A Research Study To Evaluate If Frovatriptan Is Safe And Effective In Preventing Migraine Headache After Fasting

> **NCT00440232** · NA · COMPLETED · sponsor: **Thomas Jefferson University** · enrollment: 74 (actual)

## Conditions studied

- Migraine

## Interventions

- **DRUG:** Frovatriptan
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00440232
- **Lead sponsor:** Thomas Jefferson University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2009-03
- **Final completion:** 2009-09
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2011-05-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00440232

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00440232, "A Research Study To Evaluate If Frovatriptan Is Safe And Effective In Preventing Migraine Headache After Fasting". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00440232. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*